These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 29536167)
1. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8 Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167 [TBL] [Abstract][Full Text] [Related]
2. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8 Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990 [TBL] [Abstract][Full Text] [Related]
3. The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric carcinoma. Gong LP; Chen JN; Xiao L; He Q; Feng ZY; Zhang ZG; Liu JP; Wei HB; Shao CK Hum Pathol; 2019 Mar; 85():82-91. PubMed ID: 30448221 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional analysis of immune genes in Epstein-Barr virus-associated gastric cancer and association with clinical outcomes. Sundar R; Qamra A; Tan ALK; Zhang S; Ng CCY; Teh BT; Lee J; Kim KM; Tan P Gastric Cancer; 2018 Nov; 21(6):1064-1070. PubMed ID: 29915957 [TBL] [Abstract][Full Text] [Related]
5. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer. Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576 [TBL] [Abstract][Full Text] [Related]
8. Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes? Haas M; Büttner M; Rau TT; Fietkau R; Grabenbauer GG; Distel LV Virchows Arch; 2011 Apr; 458(4):403-11. PubMed ID: 21359545 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric cancer. Kang BW; Seo AN; Yoon S; Bae HI; Jeon SW; Kwon OK; Chung HY; Yu W; Kang H; Kim JG Ann Oncol; 2016 Mar; 27(3):494-501. PubMed ID: 26673353 [TBL] [Abstract][Full Text] [Related]
10. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas. Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695 [TBL] [Abstract][Full Text] [Related]
11. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability. Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786 [TBL] [Abstract][Full Text] [Related]
12. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype. Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937 [TBL] [Abstract][Full Text] [Related]
13. Expression and prognostic roles of PIK3CA, JAK2, PD-L1, and PD-L2 in Epstein-Barr virus-associated gastric carcinoma. Dong M; Wang HY; Zhao XX; Chen JN; Zhang YW; Huang Y; Xue L; Li HG; Du H; Wu XY; Shao CK Hum Pathol; 2016 Jul; 53():25-34. PubMed ID: 26980034 [TBL] [Abstract][Full Text] [Related]
14. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes. Kim SY; Park C; Kim HJ; Park J; Hwang J; Kim JI; Choi MG; Kim S; Kim KM; Kang MS Gastroenterology; 2015 Jan; 148(1):137-147.e9. PubMed ID: 25254613 [TBL] [Abstract][Full Text] [Related]
15. CD47-targeted immunotherapy unleashes antitumour immunity in Epstein-Barr virus-associated gastric cancer. Duan Y; Li S; Huang B; Dou Y; Kong P; Kang W; Xu D Clin Immunol; 2023 Feb; 247():109238. PubMed ID: 36690192 [TBL] [Abstract][Full Text] [Related]
16. In Epstein-Barr virus-associated gastric carcinoma a high density of CD66b-positive tumor-associated neutrophils is associated with intestinal-type histology and low frequency of lymph node metastasis. Abe H; Morikawa T; Saito R; Yamashita H; Seto Y; Fukayama M Virchows Arch; 2016 May; 468(5):539-48. PubMed ID: 26915031 [TBL] [Abstract][Full Text] [Related]
17. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection. Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers. Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma. He D; Xiao L; Chen JN; Liang Q; Shao CK Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of Epstein-Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2. Guo C; Wei J; Scott RS; Chen Y; Chen Z; Zhao W; Zhang C; Wang B; Chai C; Dai G; Li M; Zhang F J Med Virol; 2020 Mar; 92(3):356-363. PubMed ID: 31663617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]